Revitalizing Biotech: Navigating Efficient Clinical Trials Amid Financial Constraints In the dynamic realm of biotech, adaptability is key to survival. Smaller biotech companies often find themselves at a critical crossroads, and conventional models of running clinical trials may no longer be sustainable. Here’s why a shift toward efficiency, global outreach, and collaboration with smaller CROs is crucial for their sustained success. 1. Extending the Read more
FDA Greenlights Groundbreaking Gene Therapies for Sickle Cell Disease The FDA has given the nod to two pioneering treatments, Casgevy and Lyfgenia, marking a significant milestone as the first cell-based gene therapies for sickle cell disease (SCD) in patients aged 12 and older. Notably, Casgevy stands out as the first FDA-approved treatment employing a novel genome editing technology, CRISPR/Cas9, marking a major leap forward Read more
Clinical Research Focus. 23rd Edition Cromos Pharma’s CEO Reflections on ESMO 2023: A Glimpse into the Future of Oncology The European Society for Medical Oncology (ESMO) 2023 conference has left the global biotech and medical community abuzz with the latest groundbreaking developments in the field of oncology. This year’s conference showcased an array of promising reports and advancements that have Read more
Shining a Spotlight on Diabetes Awareness Month: The Vital Role of Clinical Trials In the global fight against the rampant rise of Type 2 Diabetes Mellitus (T2DM), awareness and proactive measures have become paramount. This chronic metabolic disorder, marked by impaired insulin action and elevated blood glucose levels, affects millions worldwide. As we observe Diabetes Awareness Month, it’s crucial to delve into the significance of clinical trials in Read more
